Dr. Parisa Gazerani is Professor of Translational Neuropharmacology at Oslo Metropolitan University. She is recognized among the world’s top 2% most-cited scientists (Stanford–Elsevier ranking) and received the University Research Prize in 2024. Her current research focuses on brain health, neurological disorders such as headaches, and chronic pain, including major projects on barriers to education and work among youth with chronic pain and psychological distress, intelligent solutions for scoliosis treatment, and digital twins for personalized migraine care. She also leads a large-scale project on the health effects of micro- and nanoplastics.Dr. Gazerani has published over 300 scientific articles and heads the Pharmaceutical Unit at the Athens Institute for Education and Research (ATINER). Her teaching covers neuropharmacology, neuroscience, environmental toxicology, health technology, and health innovation.